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Abstract
Lipid droplets (LDs) are organelles that coordinate lipid storage and mobilization, both processes being especially important
in cells specialized in managing fat, the adipocytes. Proteomic analyses of LDs have consistently identified the small GTPase
Rab18 as a component of the LD coat. However, the specific contribution of Rab18 to adipocyte function remains to be
elucidated. Herein, we have analyzed Rab18 expression, intracellular localization and function in relation to the metabolic
status of adipocytes. We show that Rab18 production increases during adipogenic differentiation of 3T3-L1 cells. In addition,
our data show that insulin induces, via phosphatidylinositol 3-kinase (PI3K), the recruitment of Rab18 to the surface of LDs.
Furthermore, Rab18 overexpression increased basal lipogenesis and Rab18 silencing impaired the lipogenic response to
insulin, thereby suggesting that this GTPase promotes fat accumulation in adipocytes. On the other hand, studies of the b-
adrenergic receptor agonist isoproterenol confirmed and extended previous evidence for the participation of Rab18 in
lipolysis. Together, our data support the view that Rab18 is a common mediator of lipolysis and lipogenesis and suggests
that the endoplasmic reticulum (ER) is the link that enables Rab18 action on these two processes. Finally, we describe, for
the first time, the presence of Rab18 in human adipose tissue, wherein the expression of this GTPase exhibits sex- and
depot-specific differences and is correlated to obesity. Taken together, these findings indicate that Rab18 is involved in
insulin-mediated lipogenesis, as well as in b-adrenergic-induced lipolysis, likely facilitating interaction of LDs with ER
membranes and the exchange of lipids between these compartments. A role for Rab18 in the regulation of adipocyte
biology under both normal and pathological conditions is proposed.
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Introduction
White adipose tissue is essential for the maintenance of energy
homeostasis, in terms of its role both as an endocrine organ and as
the main energy reservoir of the body, responsible for storing
energy in the form of triglycerides (TAG) during periods of energy
excess and releasing it as free fatty acids (FFAs) to be used as an
energy source by other tissues during times of energy deprivation.
TAG accumulation (i.e., lipogenesis) and hydrolysis (i.e., lipolysis)
in adipocytes are primarily controlled by insulin and catechol-
amines [1,2,3], which, together with other endocrine and
paracrine/autocrine factors, ensure correct lipid storage and
utilization [4,5,6]. Alterations in adipocyte lipid metabolism, as
occur in obesity and lipodystrophy, are associated with insulin
resistance, which represents a major risk factor for the develop-
ment of type 2 diabetes, hepatic steatosis, hypertension and
cardiovascular disease [7,8].
Intracellularly, adjustments in lipid metabolism take place in
specialized organelles, the lipid droplets (LDs), in which TAG and
other neutral lipids accumulate in a central core that is surrounded
by a phospholipid monolayer and a coat of associated proteins
[9,10]. Specifically, besides the enzymes involved in lipid
biosynthesis [diacylglycerol acyltransferase 2 (DGAT2)] [11] and
hydrolysis [hormone-sensitive lipase (HSL), adipose triglyceride
lipase (ATGL)] [12], LDs are decorated with a range of proteins
that also contribute to the control of lipid storage and mobilization
and regulate LD biogenesis and movement [13]. Among these,
PAT (perilipin-adipophilin-Tip47) proteins [14] have been
extensively studied in terms of their association with the LD
surface and their role in controlling LD function [reviewed by 15].
In particular, perilipin has been shown to have a dual action on
LDs promoting TAG storage under basal conditions while
facilitating TAG lipolysis in response to b-adrenergic stimulation
[15]. In addition to the PAT family, recent proteomic studies
carried out on purified LDs have led to the identification of a large
number of other LD-associated proteins that belong to the
membrane traffic (e.g., Rab proteins) and fusion machineries (e.g.,
SNARE proteins) [13,16,17], which highlights the dynamic nature
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of these organelles. Therefore, it is now clear that LDs act as
integration centers of lipid metabolism in adipocytes and
understanding the intracellular mechanisms that control LD
biology holds the key to building a unified picture of the
(patho)physiological function of adipocytes.
Recently, the small GTPase Rab18 has been identified as a
novel protein associated with the LD surface in 3T3-L1 adipocytes
as well as in other LD-containing non-adipocyte cell lines
[13,16,18,19,20]. This GTPase has been found to regulate
intracellular membrane trafficking events in various different cells
types [21,22,23]. In adipocytes, the specific localization of Rab18
around LDs together with the observations that induction of
lipolysis in 3T3-L1 cells increased Rab18 recruitment to the
surface of LDs [18] and that Rab18 overexpression caused close
membrane apposition between LDs and ER-derived membranes
[20], led to the proposal that this GTPase might be involved in
mobilizing lipid esters stored in LDs. However, the exact
contribution of Rab18 to lipid metabolism and the mechanisms
regulating Rab18 function in adipose tissue remain to be
elucidated. In the present study, we show that, in addition to
mediating b-adrenergic action in adipocytes, Rab18 is a
downstream effector of the metabolic changes induced by insulin
in this cell type. Our data provide novel experimental evidence
supporting the involvement of this GTPase as a key mediator in
the bidirectional trafficking of lipids between LDs and the ER.
Finally, we explore the regulation of Rab18 expression in human
adipose tissue as a function of sex, adipose tissue localization and
obesity.
Results
Rab18 expression during differentiation of 3T3-L1 cells to
adipocytes
To analyze the expression pattern of Rab18 during the
differentiation of 3T3-L1 cells into adipocytes, we quantified
Rab18 mRNA content at 0, 3, 6, 10 and 12 days of differentiation
by quantitative RT-PCR. As shown in Fig. 1A, Rab18 expression
was significantly higher at all time points analyzed than in non-
differentiated cells, reaching a peak on day 3. At 6, 10 and 12 days
of differentiation, Rab18 mRNA levels tended to decrease,
although they remained approximately 75, 50 and 70% higher
than in non-differentiated cells. In turn, Rab18 protein content
was very low in non-differentiated cells, but it notably increased
after 3 days of differentiation and remained elevated thereafter
(Fig. 1C). To monitor adipogenesis, adiponectin gene expression
and protein content were quantified (Figs. 1B and 1C).
Regulation of Rab18 gene expression, protein content
and subcellular localization in 3T3-L1 adipocytes
In order to ascertain the specific contribution of Rab18 to
adipocyte function, we first studied how different extracellular
stimuli known to control lipid metabolism affect Rab18 production
and its subcellular localization in 3T3-L1 adipocytes. Regarding
Rab18 expression, 24-h treatments with either 100 nM insulin or
10 mM isoproterenol significantly increased Rab18 mRNA levels,
which accounted for by 183% and 108% above baseline levels,
respectively (Fig. 2A). Other treatments, such as 100 nM
dexamethasone and 10 nM GH, also tended to increase Rab18
gene expression, although these effects were not statistically
significant. Finally, exposure of 3T3-L1 adipocytes to 4.8 nM
pituitary adenylate-cyclase activating polipeptide-38 (PACAP38)
or 10 mM rosiglitazone did not alter Rab18 transcript levels. In
view of these results, we chose the strongest inductors of Rab18
expression (namely, insulin and isoproterenol) to explore their
effects on Rab18 protein content. As depicted in Fig. 2B, 24-h
treatment with either 100 nM insulin or 10 mM isoproterenol
elicited increases in Rab18 protein content of 38% and 59% as
compared to non-stimulated conditions, respectively. These data
indicate that Rab18 production is regulated by specific regulatory
inputs reaching the adipocytes and suggest that the GTPase may
form part of the intracellular machinery activated by such factors.
Previously, several studies have reported that Rab18 localizes at
the surface of LDs [18,20] and that isoproterenol treatment
increases this association [18]. Inasmuch as in the present work we
have found that, like isoproterenol, insulin modulates Rab18
production in adipocytes, we asked whether this hormone could
also affect intracellular localization of Rab18. To this end, 3T3-L1
adipocytes were subjected to a 4-h treatment with 100 nM insulin
and co-immunostained with antibodies against Rab18 and the
LD-surface resident, non-exchangeable protein perilipin [24], and
visualized under a confocal microscope. As a positive control, cells
Figure 1. Rab18 expression during differentiation of 3T3-L1
cells into adipocytes. (A) Quantitative RT-PCR analysis of Rab18 mRNA
levels in 3T3-L1 cells exposed to a hormonal differentiation cocktail for 0,
3, 6, 10 and 12 days. Gene expression was expressed as the ratio of target
gene concentration to the concentration of a housekeeping gene, the
18S rRNA (2.0610867.76107 and 3.26101362.261012 Rab18 and 18S
cDNA copies, respectively, per 0.1 mg total RNA in non-differentiated
cells). Three independent experiments 6 SEM were tested for
significance using the Newman-Keul’s comparison test. *, P,0.05 vs.
non-differentiated cells. (B) To monitor adipogenesis, adiponectin mRNA
transcripts (1.6610861.36108 cDNA copies/0.1 mg total RNA in non-
differentiated cells) were also quantified. (C) Representative immunoblots
from 3 independent analyses of Rab18 and adiponectin protein content
in 3T3-L1 cell extracts during differentiation. b-actin immunosignal was
used as reference for protein charge.
doi:10.1371/journal.pone.0022931.g001
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were treated with 10 mM isoproterenol and processed for
immunocytochemistry. Figure 3A shows representative images of
cells under basal conditions and cells treated with either insulin or
isoproterenol. As shown, in non-treated cells Rab18 a certain level
of immunoreactivity was detected around the LDs, displaying a
significant degree of overlap with perilipin immunofluorescence
(PC = 0.1960.05; n = 8 cells; Fig. 3A, top panels). Insulin
administration notably enhanced Rab18 immunoreactivity around
LDs and, hence, colocalization with perilipin (PC = 0.3860.07;
n = 9 cells; Fig. 3A, mid panels). Likewise, colocalization of Rab18
and perilipin also significantly increased in response to the b-
adrenergic agonist (PC = 0.3460.04; n = 8 cells; Fig. 3A, bottom
panels). To confirm the effectiveness of the treatments, we
measured the average LD size under each condition. It was found
that LDs were significantly larger in insulin-treated cells than in
controls, which is consistent with an increase in lipid deposition,
while LDs were smaller after isoproterenol stimulation, likely due
to increased TAG lipolysis (1.3960.13, 1.8260.10, and
0.1860.02 mm2 in control, insulin- and isoproterenol-treated cells,
respectively; P,0.05).
The effect of insulin and isoproterenol on Rab18 association
with LDs was also explored using subcellular fractionation in a
sucrose density gradient followed by immunoblotting of the
resulting fractions. Under basal conditions, the Rab18 immuno-
signal was mainly localized in the perilipin-enriched and
microsomal fractions (top and bottom of the gradient respectively),
although a degree of immunoreactivity was also noticeable in some
cytosolic fractions (Fig. 3B). After insulin treatment, Rab18
immunolabeling was 43% higher in the perilipin-enriched
fractions, whereas the amount of protein present in the
Figure 2. Regulation of Rab18 gene expression and protein
content in 3T3-L1 adipocytes. (A) 3T3-L1 adipocytes were treated
with 10 mM isoproterenol (ISO), 100 nM dexamethasone (DEX), 10 nM
GH, 4.8 nM PACAP (PAC), 100 nM insulin (INS), or 10 mM rosiglitazone
(ROS) for 24 h, and Rab18 mRNA levels were evaluated by quantitative
RT-PCR. 18S rRNA expression was used as internal control
(1.7610969.26108 and 1.16101261.561011 Rab18 and 18S cDNA copies,
respectively, per 0.1 mg total RNA in untreated cells). Data represent the
average 6 SEM of 3 independent experiments. *, P,0.05 vs. untreated
cells. . (B) Quantification of Rab18 band intensity in extracts from 3T3-L1
adipocytes cultured in the presence or absence of 100 nM insulin (INS) or
10 mM isoproterenol (ISO) for 24 h s. b-actin immunostaining was used
as loading control. Data are expressed as the mean 6 SEM of 3
independent experiments. *, P,0.05 vs. untreated cells. A representative
immunoblot of Rab18 and b-actin is shown.
doi:10.1371/journal.pone.0022931.g002
Figure 3. Rab18 subcellular localization in 3T3-L1 adipocytes
under insulin or isoproterenol stimulation. (A) Confocal micro-
scope images of 3T3-L1 cells under basal conditions (top panels) or
challenged with 100 nM insulin (middle panels) or 10 mM isoproterenol
(bottom panels) for 4 h and co-immunostained for Rab18 (red) and the
LD-associated protein perilipin (green). Colocalization of the two
immunosignals can be seen in the most right panels (yellow). Scale
bars, 5 mm. (B) Immunoblots of sucrose gradients from 3T3-L1 cells
under non-stimulated conditions and after 4-h treatments with 100 nM
insulin and 10 mM isoproterenol. Perilipin and calnexin immunoreactiv-
ities were used as markers of LD-enriched fractions (light fractions) and
microsomal fractions (heavy fractions), respectively. One representative
experiment out of three with similar results is shown.
doi:10.1371/journal.pone.0022931.g003
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microsomal fraction remained the same as in control conditions.
In addition, insulin provoked a slight decrease in Rab18
immunoreactivity in cytosolic fractions. Regarding isoproterenol,
this treatment induced a 48% increase in Rab18 immunoreactivity
associated with perilipin-enriched fractions, similar to that
previously reported [18], and a concomitant decrease in the
microsomal and cytosolic fractions. In sum, these findings indicate
that, as in isoproterenol-induced b-adrenergic receptor activation,
the intracellular signaling pathway initiated by insulin involves
Rab18 recruitment to the surface of LDs, which further supports
the notion of a role for this GTPase in the metabolic response of
3T3-L1 adipocytes to this hormone.
We next examined the intracellular signaling pathways that
mediate the effect of insulin and isoproterenol in Rab18
association to LDs. In adipocytes, most of the metabolic actions
of insulin are mediated by activation of phosphatidilinositol-3-
kinase (PI3K) that phosphorylates Akt, the latter being respon-
sible for the activation of various different substrates [25,26]. We
therefore investigated whether the increase in Rab18 at the
surface of LDs induced by insulin is a consequence of activation
of PI3K/Akt by quantifying the degree of colocalization between
Rab18 and perilipin immunolabeling in cells treated with insulin
in the presence of the PI3K blocker wortmannin. This showed
that in the presence of wortmannin, insulin was prevented from
increasing colocalization of Rab18 and perilipin at the surface of
LDs (PC = 0.5060.09 vs. 0.3660.02 in insulin-treated cells in the
absence and presence of wortmannin, respectively; P,0.05;
Fig. 4A). These data indicate that insulin exerts its effect on the
intracellular localization of Rab18 via activation of the PI3K/Akt
signaling cascade. In the case of isoproterenol, its effect on
lipolysis in adipocytes is mediated by activation of b-adrenergic
receptors, which initiates the adenylate cyclase (AC)/cAMP/
protein kinase A (PKA) pathway [27]. PKA phosphorylates
hormone sensitive lipase (HSL), which then translocates to the
LD surface and triggers the enzymatic reactions that lead to fatty
acid hydrolysis [28]. In the current work, we demonstrate that
the isoproterenol-induced effect on Rab18 localization is
mediated by activation of the AC/cAMP/PKA pathway,
inasmuch as blockade of either AC by treating cells with MDL
12,330A or PKA by using H89 prior to isoproterenol
administration significantly decreased colocalization of Rab18
and perilipin immunosignals on the LD surface (PC = 0.4460.05
vs. 0.2760.03 and 0.2660.07 in isoproterenol-treated cells in the
absence and presence of MDL 12,330A or H89, respectively;
P,0.05; Fig. 4B), reaching levels comparable to those obtained
in non-treated cells.
Rab18 and LD apposition to ER membranes
In a previous study, Ozeki and coworkers [20] found that
overexpression of exogenous Rab18 induced apposition of LD and
ER membrane surfaces. Herein, we have extended these findings
concerning endogenous Rab18 by demonstrating that rapproche-
ment of Rab18-bearing LDs to ER membranes is a process
regulated by extracellular inputs reaching the adipocytes,
including both insulin and b-adrenergic stimulation. Specifically,
colocalization analysis of Rab18 and the ER markers calnexin
(Fig. 5A) and protein disulfide isomerase (PDI; Fig. 5B) revealed
that, under basal conditions, there is little colocalization between
this GTPase surrounding LDs and the ER. Accordingly, the
degree of colocalization between Rab18 and calnexin or PDI
immunoreactivities was found to be very low in non-stimulated
cells. On the other hand, after insulin or isoproterenol adminis-
tration, colocalization between Rab18 and both ER markers
notably increased.
Rab18 contribution to lipogenesis
To investigate the specific contribution of Rab18 to LD
physiology, we carried out Rab18 overexpression and silencing
studies in 3T3-L1 cells. For overexpression experiments, cells were
transiently transfected with a vector coding for either Rab18 or the
constitutive active mutant Rab18(Q67L) fused to GFP. In all cases,
transfection efficiency was over 90% as assessed by fluorescence
microcopy (data not shown). Supplementary Fig. S1 (panel A)
shows the intracellular distribution of GFP-Rab18 in 3T3-L1
adipocytes under basal conditions and after insulin treatment. As
shown, exogenously expressed Rab18 mainly localized around a
particular population of Oil-Red O labeled LDs, similar to the
pattern found for endogenous Rab18. The specific GFP-Rab18
Figure 4. Intracellular signaling pathways mediating the effect
of insulin and isoproterenol on Rab18 association with LDs. (A)
Representative confocal images of 3T3-L1 adipocytes treated with
100 nM insulin for 4 h in the absence (top panels) or presence of the
PI3K blocker wortmannin (1 mM). (B) Representative confocal images of
3T3-L1 adipocytes treated with 10 mM isoproterenol for 4 h in the
absence (top panels) or presence of the PKA blocker H89 (1 mM; middle
panels) or the adenylate cyclase blocker MDL 12,330 (1 mM; bottom
panels). After treatment, cells were co-immunostained for Rab18 (red)
and perilipin (green). Colocalization of the two proteins is shown in the
images on the far right (yellow). Scale bars, 5 mm.
doi:10.1371/journal.pone.0022931.g004
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distribution around LDs can be seen in more detail in the rendered
image (Fig. S1, panel B), which illustrates Oil-Red O stained LDs,
one showing a ring-shaped coating of GFP-Rab18. Similar to what
had been previously observed in non-transfected cells, insulin
increased mean LD size in mock-transfected 3T3-L1 cells, an
effect that was not observed when cells were challenged with
isoproterenol (Fig. S1, panel C). Specifically, comparison of the
average LD size from GFP-expressing cells versus GFP-Rab18-
expressing cells revealed that, in the latter group, LDs were
significantly larger than in mock-transfected cells both under basal
conditions and after insulin administration or isoproterenol
treatment (Fig. S1, panel C). The strong effect of insulin on LD
size in Rab18-overexpressing cells as compared to GFP-transfect-
ed cells is noteworthy, and suggests that Rab18 may facilitate
insulin-mediated lipid uploading into LDs.
Quantification of the lipogenic activity in Rab18-expressing
3T3-L1 cells revealed that, under basal conditions, Rab18
overexpression provoked a 38% increase in triglyceride content,
and this seemed to be a maximal level, as insulin treatment was
unable to induce further increases. The stimulatory effect of
Rab18 on basal lipogenesis was reproduced by transfection of cells
with the constitutively active mutant Rab18(Q67L) (Fig. 6A).
For silencing studies, 3T3-L1 cells were transfected with a
synthetic siRNA, which reduced Rab18 mRNA levels by 60%, as
evaluated by real-time RT-PCR, and lowered endogenous levels
of Rab18 protein by 70%, as assessed by immunoblotting (Fig. 6B).
As shown in Fig. 7C, reduction in Rab18 expression did not
modify basal lipogenic activity but abrogated insulin-stimulated
lipogenesis. Overall, results from our overexpression and silencing
studies suggest that Rab18 facilitates triglyceride accumulation in
LDs.
Rab18 contribution to lipolysis
Given the increased association of Rab18 with the surface of
LDs upon stimulation of lipolysis ([18] and our present data), we
assessed how Rab18 overexpression and knock-down affect the
lipolytic activity of adipocytes. Specifically, we found that GFP-
Rab18 overexpression induced a 44% increase in glycerol release
under basal conditions, mimicking the effect of forskolin in mock-
transfected cells (Fig. 7A). Moreover, forskolin did not cause any
further enhancement in the lipolytic activity of cells. Likewise,
Rab18 constitutive active mutant Rab18(Q67L) also significantly
increased basal lipolysis to the same extent as seen with the wild-
type GTPase (Fig. 7A). In order to ascertain whether this effect
was restricted to fully differentiated cells, we overexpressed GFP-
Rab18 at an early stage of the differentiation process (4 days),
when cells already present b-adrenergic receptors [29] and
adenylate-cyclase activity is enhanced in response to isoproterenol
[30], and evaluated the effect of forskolin on lipolysis two days
after transfection. These results revealed that Rab18 overexpres-
sion exerted the same effect on the lipolytic rate in cells
differentiated for 6 days (data not shown) as those differentiated
for 10 days.
Regarding the effect of Rab18 silencing on lipolysis, glycerol
release was unaltered in untreated cells while forskolin adminis-
tration failed to stimulate lipolysis, as compared to cells transfected
with the negative control siRNA (Fig. 7B). These results provide
strong evidence for a role for Rab18 in TAG hydrolysis and,
together with the data obtained on insulin, suggest that this
GTPase is a molecular player common to the lipolytic and
lipogenic pathways converging in LDs.
Rab18 expression in human adipose tissue
We assessed the expression of Rab18 in both subcutaneous and
omental adipose tissue samples from lean (BMI = 21.861.3 kg/
m2; n = 8 men and 4 women) and obese (BMI = 48.262.6 kg/m2;
n = 16 men and 18 women) individuals. This latter group was
Figure 5. Effects of insulin and isoproterenol on Rab18
localization in relation to the ER. Representative confocal images
of 3T3-L1 adipocytes under basal conditions or treated with 100 nM
insulin or 10 mM isoproterenol for 4 h. After treatment, cells were co-
immunostained for Rab18 (red) and the ER markers calnexin (A) or
protein disulfure isomerase (B). In all cases, regions of interest containing
a group of Rab18-positive LDs are presented. The colocalization channel
was isolated using Imaris 6.4 (Bitplane) and shown alone in the images on
the far right. Scale bars, 2 mm. To quantify the degree of colocalization,
Pearson’ coefficients were calculated for each experimental condition
and represented as the mean6 SEM of, at least, 10 cells per experimental
group. *, P,0.05 vs. untreated cells.
doi:10.1371/journal.pone.0022931.g005
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Figure 6. Effect of Rab18 overexpression and silencing on insulin-induced lipogenesis. (A) The effect of Rab18 overexpression on basal and
insulin-induced lipogenic activity in 3T3-L1 adipocytes was assessed by transfecting cells with GFP-tagged versions of wild-type Rab18 or the
constitutively active mutant Rab18(Q67L) for 48–72 h. In parallel, a group of cells (controls) were transfected a vector expressing GFP alone. GFP
fluorescence served to confirm transfection efficiencies higher than 90% for each experiment prior to further experimental manipulation. After 4-h
treatment, cells were lysed and intracellular TAG content was quantified. TAG content was normalized to total protein content and expressed as the
mean6 SEM of 6 independent experiments. (B) Rab18 silencing was achieved by transfecting 3T3-L1 cells with a mouse Rab18 specific siRNA. As control,
a group of cells were transfected with a scramble negative control siRNA. Rab18 knock down was confirmed by quantitative RT-PCR and Western blot.
(C) After 72 h, cells were challenged to 100 nM insulin for 4 h, harvested and lysed. TAG was content quantified as indicated above and expressed as the
mean 6 SEM of 6 independent experiments. *, P,0.05 and **, P,0.01 vs. untreated control cells. #, P,0.05 vs. insulin-treated control cells.
doi:10.1371/journal.pone.0022931.g006
Figure 7. Effect of Rab18 overexpression and silencing on forskolin-induced lipolysis. (A) The effect of Rab18 overexpression on basal and
forskolin-induced lipolysis was evaluated by transfecting 3T3-L1 adipocytes with GFP-tagged, wild-type Rab18 or the constitutively active mutant Rab18(Q67L)
for 48–72 h. In each experiment, a group of cells (controls) were transfected a vector expressing GFP alone. GFP fluorescence served to confirm transfection
efficiencies higher than 90% for each experiment prior to further experimental manipulation. After 30 min in the presence or absence of forskolin, the culture
medium was collected and glycerol release measured with Free Glycerol Reagent kit (Sigma-Aldrich). Glycerol concentration in the medium was normalized to
total protein and expressed as the mean 6 SEM of 5 independent experiments. (B) Rab18 silencing was achieved by transfecting 3T3-L1 cells with a mouse
Rab18 specific siRNA. After 72 h, cells were challenged with 50 mM forskolin for 30 min. Glycerol release was quantified as indicated above and expressed as
the mean 6 SEM of 5 independent experiments. *, P,0.05 vs. untreated control cells. #, P,0.05 vs. forskolin-treated control cells.
doi:10.1371/journal.pone.0022931.g007
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divided into normoglycemic (NG; n = 5 men and 6 women),
insulin resistant (IGT; n = 5 men and 6 women), and type 2
diabetic (T2D; n = 6 men and 6 women) subjects. We first
explored the subcellular distribution of the GTPase in isolated
mature adipocytes from lean individuals, finding that Rab18
immunoreactivity is associated with the surface of LDs in
adipocytes from both omental and subcutaneous fat (Fig. S2).
Consistently, RT-PCR analysis revealed that Rab18 mRNA is
expressed in both adipose tissue depots, but transcript levels of the
GTPase were higher in subcutaneous adipose tissue than in
omental fat irrespective of the sex of the individual (Table S1). On
the other hand, Rab18 gene expression levels were higher in both
fat depots in lean women with respect to lean men, although
differences between the sexes only reached statistical significance
in omental adipose tissue (Table S1).
When the mRNA data from the three groups of obese
individuals were analyzed together, no differences for Rab18
levels were observed as a function of sex (Table S1). Similar Rab18
mRNA levels were observed in the two fat depots in obese women
whereas in obese men Rab18 transcript levels were higher in
subcutaneous than in omental fat (Table S1). Specifically, Rab18
expression in omental adipose tissue was upregulated by 237, 154
and 188% in normoglycemic, insulin resistant and T2D obese
women, respectively, whereas no significant differences were found
in the subcutaneous depot between lean and obese women
(Figs. 8A and 8B). In contrast, Rab18 mRNA levels were higher in
both omental and subcutaneous fat in obese men than in lean men
(Fig. 8C and 8D), although the greatest differences in Rab18
mRNA content between obese and lean patients were found in the
former depot. Further, Rab18 transcript content in omental
adipose tissue from T2D men, though numerically higher than
that observed in lean men, was not significantly different from
either this group or the levels observed in the other groups of obese
patients (Fig. 8C).
Finally, the protein expression of Rab18 in adipose tissue
samples from lean and obese individuals exhibited a similar
pattern to that observed in the gene expression analysis (Fig. 8E).
Discussion
LDs are highly dynamic and complex organelles specialized in
intermembrane lipid transport and responsible for lipid metabo-
lism [16]. Several independent proteomic studies aimed at
isolating and characterizing the protein composition of the LD
surface have strongly supported this view, as they led to the
identification of a plethora of proteins, many of which are directly
related to intracellular membrane trafficking and fusion events (i.e.,
Rab, SNARE and motor proteins) [17,31,32,33]. Herein, we
provide experimental evidence supporting a role for a member of
the Rab family, Rab18, in adipogenesis as well as in mediating the
lipogenic and lipolytic actions of insulin and isoproterenol,
respectively, on 3T3-L1 adipocytes. Moreover, we have identified
the intracellular pathways responsible for the Rab18 association
with LDs and provided experimental evidence that this process
entails rapprochement of LDs to ER membranes. Finally, we have
demonstrated, for the first time, the presence of Rab18 in human
adipose tissue and showed that the expression of this GTPase is
correlated to obesity.
Studies in differentiating 3T3-L1 cells, the cell line most
commonly used to study adipogenesis, revealed that Rab18
mRNA reached a maximal level on day 3 of differentiation,
coinciding with the appearance of late differentiation markers (i.e.
lipogenic and lipolytic enzymes, as well as several LD-coating
proteins such as perilipin), which are responsible for the
maintenance of the adipocyte phenotype in 3T3-L1 cells
[34,35]. In addition, Rab18 protein content progressively
increased during differentiation. These data indicate that, as
previously suggested for other Rab proteins (namely, Rab3A and
Rab3D) [36,37], Rab18 may play a role in the differentiation of
3T3-L1 fibroblasts to mature adipocytes. Notably, we found that
insulin, a key component of the hormonal cocktail employed to
induce this process in 3T3-L1 adipocytes [38], up-regulated
Rab18 expression and increased Rab18 protein content in these
cells. Furthermore, this hormone also triggered Rab18 association
with LDs, a process that seems to be mediated by activation of the
key upstream regulator of the metabolic actions induced by insulin
in adipocytes, PI3K [25]. Similar to the pattern observed herein
for Rab18, previous studies have reported that insulin induces
other coating proteins to localize with LDs, including S3–12
[39,40] and OXPAT [41]. Moreover, it has been shown that
insulin, via PI3K, induces the activation and intracellular
redistribution in adipocytes of another member of the Rab family,
Rab4, which is involved in GLUT-4 vesicle trafficking [42]. These
findings suggest that Rab proteins and, in particular Rab18, may
be part of the intracellular machinery transducing the metabolic
effects of insulin in this cell type. In line with this notion, the
increase in Rab18 association with LDs induced by insulin
concurred with the stimulation of intracellular TAG accumulation
evoked by this hormone and, in addition, this later effect was
inhibited in Rab18-silenced cells. These data support the view that
insulin-induced recruitment to LDs may contribute to the
lipogenic action of this hormone. A role for Rab18 in promoting
lipogenesis is further backed by our observations of the increased
lipogenic rate and LD size evoked by the overexpression of this
GTPase in 3T3-L1 cells.
Intriguingly, the effects of insulin on the expression and
intracellular localization of Rab18 were strikingly similar to those
induced by b-adrenergic receptor activation which, as is widely
known and also shown in this study, has an opposite effect to that
of insulin on lipid metabolism. Moreover, Rab18 overexpression
increased TAG hydrolysis at both early and late stages of 3T3-L1
cell differentiation, and Rab18 silencing blunted forskolin-
stimulated lipolysis in differentiated 3T3-L1 cells. Overall, these
data provide evidence for the participation of this GTPase in the
regulation of lipolysis. When these results are viewed together with
those obtained concerning the response to insulin, a role for
Rab18 as a common mediator in lipogenic and lipolytic processes
seems plausible. Although this dual contribution of Rab18 to the
regulation of lipid metabolism may seem paradoxical, other
proteins have been shown to affect these antagonistic processes in
a similar manner. For example, ATGL and its coactivator CGI-
58, besides their well-known role in TAG hydrolysis [43], also
exhibit acyltransferase activity and, therefore, are able to promote
lipogenesis [44,45,46]. However, the relative contribution of these
contrasting functions remains unknown so far. In the case of
Rab18, our findings that both insulin and isoproterenol increased
the colocalization of this GTPase with ER markers, which is
consistent with previous observations obtained in 3T3-L1 cells
overexpressing Rab18 [20], suggest that the ER is the joining-
point that enables Rab18 action to affect lipolysis and lipogenesis.
In line with this, when lipid homeostasis demands fatty acid
storage via insulin-induced lipogenesis, fatty acids are taken up by
cytosolic fatty acid binding proteins and transported into the ER
lumen for further processing to triglycerides [reviewed in
15,24,47]. Finally, lipid esters are loaded into LDs by a process
that, although not yet well understood, appears to rely upon
interaction of the surface of LDs with specialized regions of ER
membranes [13]. On the other hand, during b-adrenergic
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receptor-induced lipolysis, the products derived from triglyceride
hydrolysis are thought to be unloaded into the ER lumen as a
result of the apposition and direct contact of the LD phospholipid
monolayer and the ER membrane, which will ultimately cause
depletion of LD lipid content and, eventually, LD regression [13].
Thus, given the close physical and functional interactions between
LDs and ER membranes, combined with the general function of
Rab GTPases in intracellular membrane trafficking [48], it is
tempting to speculate that the presence of Rab18 on LDs may
entail bringing LDs and ER membranes together, which would
facilitate lipid loading and/or unloading from and to the ER
reservoir depending on the metabolic demands of adipocytes.
Consistent with this idea, a role for Rab18 in regulating tethering
and/or fusion events on ER membranes has been recently
proposed [21,22,23]. Mechanistically, Rab proteins accomplish
their functions by activating downstream effectors that ultimately
affect the molecular machinery of a particular process [49]. For
example, Rab27A is involved in controlling trafficking of secretory
granules in a wide variety of secretory cells through interaction
with cell-type- and tissue-specific Rab27A effectors [50]. In
particular, when Rab27A recruits Slp4-a, cells dramatically
decrease their hormone secretion rate [51], whereas when
Rab27A binds rabphilin, the secretory activity of the cells greatly
increases [52]. In this scenario, it is plausible that, depending on
Figure 8. Assessment of Rab18 expression levels in human adipose tissue in relation to obesity and insulin resistance. Omental and
subcutaneous adipose tissue samples were obtained from the abdominal region of women (A and B) and men (C and D) with different degrees of
obesity and/or insulin-resistance: lean, obese normoglycemic (NG), obese with impaired glucose tolerance (IGT) and obese type 2 diabetic (T2D)
patients. After removal, tissue samples were processed for total RNA extraction. Rab18 expression was evaluated by quantitative RT-PCR using
specific primers for human Rab18. The expression of human 18S rRNA in each sample was evaluated as an internal housekeeping gene. Absolute
cDNA copy number for lean patients were 2.1610561.76105 Rab18 copies and 6.66101065.561010 18S copies in omental fat from women,
5.9610463.16104 Rab18 copies and 5.76101061.561010 18S copies in omental fat from men, 4.9610463.26104 Rab18 copies and
1.16101066.96109 18S copies in subcutaneous fat from women, and 5.2610462.06104 Rab18 copies and 2.86101061.36109 18S copies in
subcutaneous fat from men. *, P,0.05 vs. lean subjects. (E) Rab18 protein content in omental and subcutaneous adipose tissue samples from lean
and obese women and men. In each blot, the b-actin immunosignal from the same sample was used as internal control.
doi:10.1371/journal.pone.0022931.g008
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the extracellular input reaching adipocytes (i.e. insulin or
catecholamines), Rab18 interacts with different effector proteins,
which in turn results in the repositioning of LDs to appropriate
locations relative to specific subdomains of the ER specialized in
either lipogenesis or lipolysis [13,16]. Alternatively, given the
demonstrated heterogeneity of LDs within cells in terms of their
repertoire of coating proteins [12], lipogenic or lipolytic stimuli
may target Rab18 to distinct LD subpopulations specialized in
lipid storage or breakdown. Unfortunately, the specific Rab18
effectors in adipocytes remain to be identified. Ongoing
experiments in our laboratory are focused on the identification
of Rab18 interacting proteins in adipose tissue, which would pave
the way for a better understanding of Rab18 function in relation to
lipid metabolism.
Based on our findings on Rab18 in 3T3-L1 cells and given the
relationship between human obesity and obesity-associated T2D
and altered adipocyte lipid metabolism [53], we examined Rab18
in human adipose tissue in subjects with different metabolic
conditions. To our knowledge, this is the first report on the
characterization of a member of the Rab family in human fat in
relation to sex, depot, degree of adiposity and insulin sensitivity. In
particular, we have demonstrated that, similarly to what is seen in
3T3-L1 cells ([18] and this study), Rab18 also coats the surface of
LDs in human adipocytes. We found both sex- and depot-related
differences in Rab18 expression in non-obese subjects, with
women vs. men and subcutaneous vs. omental adipose tissue
showing higher mRNA and protein levels of this GTPase. These
differences might reflect the distinct, sex-dependent metabolic
activity of omental and subcutaneous adipose tissue [54]. Further,
it has been shown that, compared with omental adipocytes,
subcutaneous adipocytes in non-obese women are larger, have
higher LPL activity, and are more lipolytic on an absolute basis,
which may underlie the higher fat storage capacity in this depot in
women [55]. Additionally, in both sexes subcutaneous adipocytes
are more sensitive to insulin actions than visceral adipocytes
[reviewed by 56], yet the opposite holds true for catecholamines
[54,56]. On the other hand, no differences sex-related differences
in Rab18 gene expression were detectable in obese individuals,
mainly due to the significant upregulation of Rab18 mRNA levels
observed in both fat depots in morbidly obese men. Indeed, except
for the subcutaneous depot in women, obesity was associated with
an increase in Rab18 expression, which suggests that upregulation
of this GTPase may be an appropriate response to managing
energy excess. Nevertheless, these results were unexpected as
recent studies in humans, based either on microarray data [57]
and on the analysis of the expression of specific proteins involved
in lipolysis (i.e. HSL; [58]) or lipogenesis (i.e. FAS; [59]), suggest
that both processes are decreased in severely obese subjects. In this
scenario, it is tempting to speculate that the enhanced expression
of Rab18 in obese individuals is an adaptive response to overcome
the alterations in lipid metabolism occurring in obesity. Finally,
although we observed a tendency toward lower Rab18 mRNA
expression in obese T2D individuals compared to obese NG and
IGT patients (specifically in omental fat in men), there does not
appear to be an apparent association between the expression of
this GTPase and insulin sensitivity.
In conclusion, our data provide novel insights concerning the
distribution and function of Rab18 in adipocytes. Specifically,
through its interaction with the surface of LDs and, most likely,
with ER membranes, Rab18 regulates adipocyte lipid metabolism
in response to both lipogenic (insulin) and lipolytic (b-adrenergic)
inputs. In humans, Rab18 is associated with the surface of LDs in
adipocytes and its expression in adipose tissue, which displays sex-
and depot-related differences, correlates with increased adiposity,
providing evidence for the participation of this GTPase in the
regulation of human adipocyte biology under both normal and
pathological conditions.
Materials and Methods
Cell culture and in vitro experimental setups
3T3-L1 cells [obtained from the American Type Culture
Collection (Manassas, VA)] were differentiated into adipocytes, as
previously described [60]. Briefly, 100% confluent cells (day 0)
were incubated in DMEM containing 10% FBS, 0.5 mM
isobutylmethylxanthine (IBMX), 0.25 mM dexamethasone and
10 mg/ml insulin for 72 h (day 3). The medium was replaced by
DMEM with 10% FBS and 10 mg/ml insulin for an additional 72-
h period (day 6) and was then exchanged by DMEM without
insulin until day 10, when all the experiments were carried out.
Rab18 and adiponectin mRNA expression and protein content
during adipocyte differentiation were assessed in 3T3-L1 cells at
days 0, 3, 6 and 10 of differentiation. The hormonal control of
Rab18 expression in 3T3-L1 cells was evaluated at day 10 of
differentiation by preincubating cells in 1 ml serum-free culture
medium for 2 h and then treating them with 10 mM isoproterenol,
100 nM dexamethasone, 10 nM GH, 4.8 nM PACAP38, 100 nM
insulin, or 10 mM rosiglitazone. After a 24-h treatment period,
cells were resuspended in 1 ml TRIzol Reagent (Invitrogen Corp.,
Barcelona, Spain) and processed for RNA analysis. After
treatment of cells with 100 nM insulin or 10 mM isoproterenol
for 24 h, Rab18 protein and adiponectin levels were determined
by Western blot using an anti-rat Rab18 antibody (1:500;
Calbiochem, Barcelona, Spain) and an anti-mouse adiponectin
antibody (1:5000; Chemicon Int. CA).
The effect of insulin and isoproterenol on the intracellular
distribution of Rab18 and the contribution of different compo-
nents of the corresponding signaling pathways were investigated
by immunocytochemistry. Specifically, 3T3-L1 cells were treated
with insulin (100 nM) in the presence or absence of the PI3K
inhibitor wortmannin (1 mM) for 4 h. Parallel cultures were
exposed to isoproterenol (10 mM) alone or in combination with the
AC blocker MDL 12,330A (1 mM) or with the PKA blocker H89
(1 mM) for 4 h. All inhibitors were added alone to cell cultures
90 min prior to the 4-h combined treatment.
Quantification of Rab18 gene expression by real-time
RT-PCR
For studies in 3T3-L1 cells, 2 mg of total RNA were used for RT
and subsequent real-time PCR using SYBR Green tagging
quantification in an iCycler IQ PCR detection system (Bio-Rad,
Madrid, Spain). The specific primer pair used for Rab18 was 59-
CTCTGAAGATACTCATCATCGG-39 sense and 59-CCTCT-
CTTGACCAGCTGTATCCCA-39 antisense, which amplify a
185-bp fragment, and that used for adiponectin was 59-GTC-
CCGGAATGTTGCAGTAG-39 sense and 59-TGGAGAAGC-
CGCTTATGTGT-39 antisense. As an endogenous reference
gene, the 18S small subunit ribosomal RNA gene was amplified in
parallel to Rab18 using the specific primer pair 59-CCCATTC-
GAACGTCTGCCCTAT-39 sense and 59-TGCTGCCTTCC-
TTGGATGTGGTA-39 antisense, which amplify a 137-bp
fragment.
Immunocytochemistry
3T3-L1 adipocytes were fixed with 4% paraformaldehyde
(15 min), incubated with PBS containing 0.1% saponin and 1%
BSA (1 h at RT), and exposed to anti-rat Rab18 antibody (1:500;
Calbiochem) or anti-human Rab18 (1:100; Sigma Aldrich) in
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combination with guinea pig anti-human perilipin (1:100; Progen,
Heidelberg, Germany). When Rab18 was used in combination
with mouse monoclonal anti-human calnexin (1:50; Abcam,
Cambridge, UK) or mouse monoclonal anti-rat protein disulfide
isomerase (PDI) (1:50; Abcam), cell permeabilization was assessed
with PBS containing 0.3% Triton-X-100 and 1% BSA (1 h at
RT). After incubation of cells with the primary antibodies
overnight at 4uC, the immunoreaction was revealed with an
anti-rabbit Alexa594-conjugated secondary antibody (1:500;
Invitrogen Corp.) alone or in combination with anti-guinea pig
or anti-mouse Alexa488-conjugated secondary antibodies (1:500;
Invitrogen Corp.). Samples were visualized under a TCS-SP2-
AOBS confocal laser scanning microscope (Leica Corp., Heidel-
berg, Germany). Image stacks were deconvoluted using the
Huygens Essential software package (version 2.4.4; (SVI, Hilver-
sum, The Netherlands). The degree of colocalization was
estimated by determining an overlapping pixel map of the two
fluorescent channels (i.e., a mask) using the Colocalization Finder
plugin for ImageJ 1.32 (NIH, Bethesda, MA), as previously shown
[61] and Imaris 6.4 (Bitplane, Zurich, Switzerland). The
colocalization was then quantified using Pearson’s coefficient
(PC), a value that is not sensitive to the intensity of the background
or that of the overlapping pixels. This coefficient takes a value
between 21 and +1, with 21 representing no overlap whatsoever
between images and +1 a perfect overlap of the channels. Negative
control samples without the primary antibody were included to
assess non-specific staining.
Western blot analysis
Protein extracts were obtained from cells lysed in buffer
containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1%
Triton-X-100, 1 mM EDTA, and 1 mg/ml anti-protease cocktail,
and then 150 mg of total protein was loaded onto 12.5% SDS-
PAGE gels. Rabbit polyclonal antibodies against rat Rab18
(Calbiochem) and b-actin (Sigma-Aldrich, London, UK) were
dispensed overnight at 4uC and peroxidase-conjugated secondary
antibodies were administered for 1 h at room temperature. The
immunoreaction was visualized using ECL plus (GE Healthcare,
Buckinghamshire, UK) and band intensities were assessed using
ImageJ 1.32 (NIH). Data were normalized to the corresponding b-
actin band intensities.
Subcellular fractionation
Subcellular fractionation was performed as previously described
[62]. 3T3-L1 adipocytes were incubated in the presence or
absence of 100 nM insulin and 10 mM isoproterenol for 4 h.
Then, cells were rinsed with Ca2+- and Mg2+-free medium (D-
PBS; Invitrogen Corp.) and resuspended in 3 ml lysis buffer
containing 25 mM Tris-HCl, 100 mM KCl, 1 mM EDTA, 5 mM
EGTA and 1 mg/ml anti-protease cocktail (pH 7.4). Cells were
disrupted and mixed with an equal volume of lysis buffer
containing 1.08 M sucrose and extracts were centrifuged at
1,500 g for 10 min. Supernatants were transferred to a 12-ml
ultracentrifuge tube and sequentially overlaid with 2 ml each of
0.27 M and 0.135 M sucrose buffer and, finally, free-sucrose
solution containing 25 mM Tris-HCl, 1 mM EDTA, and 1 mM
EGTA (pH 7.4). After centrifugation at 130,000 g (1 h, 4uC), 8
fractions of 1.5 ml each were collected. After protein precipitation,
extracts from each fraction were analyzed by Western blot as
described above.
Electroporation
3T3-L1 adipocytes were electroporated as previously described
[63]. Briefly, cells cultured on 150-mm Petri dishes were
mechanically resuspended, washed twice with D-PBS and
submerged into 100 ml D-PBS containing 50 mg of the corre-
sponding plasmids or 2 nmol siRNAs. Electroporation was
performed in 2-mm thick electroporation cuvettes using a Gene
Pulser Xcell (Bio-Rad), which delivered a 500 mF pulse at 110 V.
After electroporation, cells were plated onto 35-mm dishes and
allowed to recover in DMEM supplemented with 10% FBS for
48–72 h. For overexpression analysis, cells were electroporated
with a phrGFP expression vector (mock-transfected cells), or with
expression vectors coding for GFP-Rab18 or for a constitutively
active mutant of Rab18 [namely, Rab18(Q67L)] fused to GFP,
and cultured for 48 h prior to the experiments. For silencing
studies, 2 nmols of a Rab18-targeted commercial double stranded
siRNA oligonucleotide (Applied Biosystems-Ambion, Austin, TX)
or a specific scramble negative control siRNA purchased from the
same company were used. After electroporation, cells were kept in
culture for 72 h before measuring lipolytic and lipogenic activities.
GFP-Rab18 overexpression was confirmed by fluorescence
microscopy and Western blot, and Rab18 silencing rate was
estimated by quantitative RT-PCR and Western blot.
Analysis of LD number and size
3T3-L1 adipocytes were electroporated with either the GFP
plasmid (i.e., mock-transfected cells) or with the GFP-Rab18
overexpression vector and cultured for 48 h. After that, cells were
maintained in serum-free medium for 2 h, and incubated in the
presence or absence of 10 mM isoproterenol or 100 nM insulin for
1 h. Then, cells were fixed with 4% paraformaldehyde, washed
with 60% isopropanol and incubated with Oil Red O solution
(Sigma-Aldrich) for 30 min. Samples were then visualized by
confocal microscopy. Ten cells per experimental condition were
randomly selected and the average LD number and size per cell
was estimated using ImageJ 1.32 (NIH).
Assessment of lipogenesis and lipolysis
Lipogenesis was measured in 3T3-L1 cells either overexpressing
GFP, GFP-Rab18 or GFP-Rab18(Q67L) vectors or silenced for
Rab18 expression, treated or not with 100 nM insulin for 4 h.
Cells were lysed in RIPA buffer (0.1% SDS, 1% Triton-X-100,
5 mM EDTA, 1 mM Tris HCl, 150 mM NaCl and 1%
deoxycholate; pH 7.4) and intracellular triglycerides quantified
using an InfinityTM Triglycerides Liquid Stable Reagent kit
(Thermo Electron Corp., Grenoble, France). Triglyceride levels
were normalized to total protein content.
Lipolysis was also quantified in overexpressing or silenced cells.
To this end, cells were incubated in the presence or absence of
50 mM forskolin for 30 min and extracellular glycerol measured by
using a Free Glycerol Reagent kit (Sigma-Aldrich). In this case,
intracellular protein content was used for normalization.
Human studies
Samples of omental and subcutaneous adipose tissue were
obtained from the abdominal region of 46 Caucasian individuals
(24 men and 22 women) undergoing either a Roux-en-Y gastric
bypass (n = 34) or laparoscopic surgery procedures (Nissen
fundoplication for hiatus hernia repair or cholecystectomies)
(n = 12). Body mass index (BMI) was calculated as weight in
kilograms divided by the square of height in meters and obesity
was classified according to body mass index (BMI$30 kg/m2.
Obese patients were classified into three groups [normoglycemic
(NG), with impaired glucose tolerance (IGT) or type 2 diabetes
(T2D)] following the criteria of the Expert Committee on the
Diagnosis and Classification of Diabetes, based on both fasting
serum glucose concentrations and 2-h plasma glucose levels
Rab18 Function in Adipocytes
PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22931
following an oral glucose tolerance test [64]. Subjects with T2D
were not on insulin therapy or on medication likely to influence
endogenous insulin levels. Immediately after removal, samples
were washed in DMEM (Invitrogen Corp.) and divided into 2–3
pieces, which were either frozen in liquid nitrogen and stored at
280uC for subsequent gene expression analysis or immediately
processed for the separation of mature adipocytes. All investiga-
tions reported were carried out in accordance with the principles
of the Declaration of Helsinki as revised in 2008. The
experimental design was approved by the Ethical Committees
responsible for research of the Clı´nica Universidad de Navarra
(Pamplona, Spain), Hospital Clı´nico Vı´rgen de la Victoria
(Ma´laga, Spain) and Hospital Universitario Reina Sofı´a (Co´rdoba,
Spain). Written informed consent was obtained from all
participating patients.
All samples from the different patients were processed separately
and considered as individual observations. RNA was extracted
from each adipose sample using an RNeasy lipid tissue kit (Qiagen
Madrid, Spain) following the manufacturer’s protocol. Integrity
and concentration of RNA were checked with a 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA). The expression levels of
the Rab18 gene, and of 18S ribosomal RNA (rRNA) as
housekeeping gene, were measured by RT-PCR using an
iCyclerTM Real-Time PCR System (Bio-Rad Laboratories).
Specifically, 1 mg of total RNA was reverse transcribed in a 20-
ml final volume using random hexamers (Roche, Barcelona, Spain)
as primers and 200 units of M-MLV reverse transcriptase
(Invitrogen Corp.). Real-time PCR was carried out with 1 ml of
cDNA and 24 ml of reaction mixture [12.5 ml of 2 X SYBR Green
Supermix (Bio-Rad)], 9.5 ml of RNase-free water and 1 ml of the
corresponding primers (Rab18: sense, 59-CCCTGAAGATCCT-
CATCATCGG-39; antisense, 59-CCTCTCTTGACCAGCAG-
TATCCCA-39 and 18S: sense, 59-CCCATTCGAACGTCTG-
CCCTATC-39; antisense, 59-TGCTGCCTTCCTTGGATG-
TGGTA-39). After an initial hold of 2 min at 94uC, samples were
cycled 40 times at 94uC for 15 s and at 61uC for 15 s. For
quantitative analysis, a standard curve-based method was used for
relative real-time PCR data processing. The expression of Rab18
gene was normalized to that of the housekeeping gene. All
measurements were performed in duplicate and the average values
were calculated. Controls consisting of reaction mixture without
cDNA were negative in all runs.
An additional set of adipose tissue samples from lean and obese
women and men was employed for assessment of Rab18 protein
levels. To this end, tissues were homogenized and levels of Rab18
protein were assessed by immunoblotting as described earlier for
3T3-L1 cells.
For the isolation of mature adipocytes, freshly isolated
subcutaneous and omental samples were incubated in Krebs-
Ringer Hepes medium (119 mM NaCl, 4.7 mM KCl, 1.2 mM
MgSO4, 2.5 mM CaCl2, 1.2 mM KH2PO4, 20 mM Hepes
pH 7.4, 2 mM glucose, 2% BSA) with 400 a.u./ml of collagenase
(Sigma-Aldrich) at 37uC for 1 h in a shaking bath. Undigested
tissue was removed by filtering through a sterile 100 mm pore Cell
Strainer (BD Falcon, CA) and centrifuged at 600 g for 10 min to
separate the floating mature adipocyte layer. Mature adipocytes
were washed with DMEM and then processed for Rab18
immunostaining as described above.
Statistical analysis
Data from 3T3-L1 cells were obtained from a minimum of
three replicate wells per treatment from, at least, three
independent experiments. Average LD size was assessed from
200–300 LDs from 10 randomly selected cells per experimental
condition. Single comparisons were performed using the Student’s
t test, while multiple comparisons were assessed by one-way
ANOVA followed by a Newman-Keuls test using GraphPad Prism
4 (La Jolla, CA). Differences were considered statistically
significant if P,0.05.
Supporting Information
Figure S1 Associated with Figure 6. Effect of Rab18
overexpression on LD size. (A) GFP (top panels) or GFP-
Rab18 (bottom panels) transfected 3T3-L1 adipocytes were
incubated in the absence (left panels) or presence of 100 nM
insulin (middle panels) or 10 mM isoproterenol (right panels) for
1 h. LDs were visualized by Oil-Red-O staining as indicated in
‘‘Material and Methods’’. GFP was always found diffuse within
cells irrespective of the treatment, whereas GFP-Rab18
accumulated, at different extent, around LDs that exhibit an
ample range of sizes. Scale bars, 5 mm. (B) High magnification
3D reconstruction of Oil-Red-O-stained LDs within a cell
expressing GFP-Rab18. Twenty confocal slices of a 3T3-L1
adipocyte were projected in a single image and a region of
interest renderized using Imaris 6.4. software (Bitplane, Zurich,
Switzerland). As shown, exogenous Rab18 adopts a ring-like
distribution around LDs, similarly to that observed for
endogenous Rab18. Scale bar, 0.25 mm. (C) Analysis of the
average LD size revealed that Rab18 overexpression induces a
general increase in LD size irrespective of the treatment. Data
are presented as the mean 6 SEM of, at least, 200 LDs per
experimental group. *, P,0.05, **, P,0.01, and ***, P,0.001
vs. groups indicated in the graph.
(TIF)
Figure S2 Associated with Figure 8. Rab18 localization in
dispersed, mature human adipocytes. Representative confocal
images of human adipocytes from omental (top panels) and
subcutaneous (bottom panels) fat depots. Adipose tissue samples
were enzymatically and mechanically dispersed as indicated in
‘‘Material and Methods’’. Then, cells were processed for
immunostaining against Rab18. A single middle plane is shown.
Rab18 immunoreactivity was found around the large LD
characteristic of mature adipocytes, as well as around small LDs
(insets). DAPI was used for labeling nuclei. Scale bars; 20 mm.
(TIF)
Table S1 Associated with Figure 8. Rab18 cDNA copy
number/18S cDNA copy number in omental and subcutaneous
adipose tissue from lean and obese women and men, as
determined by quantitative RT-PCR. Values represent means 6
SEM of, at least, 4 individuals, a, P,0,05 vs. omental adipose
tissue from lean men; b, P,0,05 vs. omental adipose tissue from
lean women; c, P,0,05 vs. omental adipose tissue from lean men;
d, P,0,001 vs. omental adipose tissue from obese men.
(DOCX)
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